Heart Disease News and Research

Latest Heart Disease News and Research

Novel synthetic HDL-C injection shows no benefit on arterial plaques

Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

Online behavioral intervention reduces systolic blood pressure by 10 mmHg, study finds

In the first randomized, double-blinded trial of an online behavioral intervention for high blood pressure, participants in web-based lifestyle counseling reduced their systolic blood pressure (the higher number in a blood-pressure reading) by 10 mmHg, compared with a 6 mmHg reduction for those taking part in a web-based control intervention, a statistically significant difference.

20 Mar 2017

Reirradiation using proton therapy offers new hope for patients with recurrent lung cancer

A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment. In the largest analysis to date of reirradiation using intensity-modulated proton therapy for lung and other thoracic tumors, more than three-fourths of patients were free from local recurrence at one year following retreatment, and fewer than one in ten patients experienced severe side effects.

17 Mar 2017

Research shows SBRT as viable curative option for older lung cancer patients

Patients in their 80s and 90s who have early stage lung cancer but cannot undergo an operation can be treated safely and effectively with stereotactic body radiation therapy (SBRT), according to research presented today at the 2017 Multidisciplinary Thoracic Cancers Symposium.

17 Mar 2017

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

Findings from a large, community-based study show that antithrombotic therapy doesn't decrease low-risk atrial fibrillation patients' risk of suffering a stroke within five years. In fact, researchers found that low-risk patients fared better without any antithrombotic therapy.

17 Mar 2017

URI researchers awarded federal funding to improve environmental, behavioral health

Pilot Projects involving two researchers at the University of Rhode Island have been awarded federal funding through Advance Clinical and Translational Research, a statewide effort to support clinical research that can be translated into approaches and policies that improve the health of Rhode Islanders.

17 Mar 2017

Palliative care consults for advanced cancer patients linked to improvement in multiple quality measures

Cancer patients admitted to the hospital with advanced stages of disease who were referred early to palliative care had decreased health care utilization and increased use of support services following discharge, according to a new study led by researchers at the Icahn School of Medicine at Mount Sinai. c

17 Mar 2017

Scientists discover new cell structure responsible for unexplained rejections after organ transplant

Drs. Marie-Josée Hébert and Mélanie Dieudé have discovered a new cell structure responsible for previously unexplained rejections following an organ transplant.

17 Mar 2017

High levels of two biomarkers can predict risk for adverse cardiac events, research suggests

New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.

17 Mar 2017

Immune cells could be new target to treat type 2 diabetes, hypertension in overweight people

Immune cells which are reduced in number by obesity could be a new target to treat diseases such as type 2 diabetes and hypertension that affect overweight people, according to a collaborative study between The University of Manchester, Lund University and the University of Salford.

From The University of Manchester 17 Mar 2017

Moderate exercise may benefit patients with hypertrophic cardiomyopathy

As one of the most common causes of sudden cardiac death in young people, a diagnosis of hypertrophic cardiomyopathy can push patients into sedentary lifestyles.

17 Mar 2017

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.

17 Mar 2017

Researchers use Syngene’s G:BOX Chemi XRQ image analysis system in cardiac research

Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce that the G:BOX Chemi XRQ high resolution, multi-application image analysis system is being successfully used at the Lithuanian University of Health Sciences Academy of Medicine to study molecular mechanisms of cardiac stem cell function which could help in developing stem cell therapies for heart repair.

From Syngene 17 Mar 2017

Northumbria University uses G:BOX Chemi XX6 multi-application imager in biomedical research

Syngene, a world-leading manufacturer of image analysis solutions, today announced its G:BOX Chemi XX6 is being used by scientists at Northumbria University for imaging chemiluminescent enzymes and other proteins on Western blots. This is contributing to rapidly providing researchers with accurate information on changes in protein in chronic conditions such as diabetes, heart disease and cancer.

From Syngene 17 Mar 2017

Nocturia is the top cause of sleep disturbance

‘On World Sleep Day sleep experts encourage people to understand the value of healthy and solid sleep. In particular, if they need to go to the toilet more than once in the night they have nocturia, a condition which affects one in three adults over the age of 30 and two thirds of adults over the age of 65.’

17 Mar 2017

Study finds reductions in volume of gray matter in the brains of children with obstructive sleep apnea

A study comparing children between 7 and 11 years of age who have moderate or severe obstructive sleep apnea to children the same age who slept normally, found significant reductions of gray matter - brain cells involved in movement, memory, emotions, speech, perception, decision making and self-control - in several regions of the brains of children with sleep apnea.

17 Mar 2017

Mount Sinai researchers review progress made in using ketamine and other therapies to treat depression

Major depressive disorder (MDD) impacts 15 million Americans and is the leading cause of disability, yet current treatments possess limited efficacy.

17 Mar 2017

Fat cells take over production of uridine from liver during fasting

How do mammals keep two biologically crucial metabolites in balance during times when they are feeding, sleeping, and fasting? The answer may require rewriting some textbooks.

17 Mar 2017

Why don’t patients always discuss hyperglycemia with their doctor?

Hyperglycemia occurs when a patient has higher than normal blood sugar levels. If the levels are very high, consistently 13-14 or above, the patient will start to feel tired, thirsty and feel the urge to go to the toilet frequently to pass urine (micturition).

17 Mar 2017

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

The Sohn Conference Foundation today unveiled the Sohn Collaborative for Liquid Biopsy at Weill Cornell Medicine to develop a blood test that will predict how cancer spreads in both children and adults.

17 Mar 2017

Heart Disease News and Research

Latest Heart Disease News and Research

Novel synthetic HDL-C injection shows no benefit on arterial plaques

Online behavioral intervention reduces systolic blood pressure by 10 mmHg, study finds

Reirradiation using proton therapy offers new hope for patients with recurrent lung cancer

Research shows SBRT as viable curative option for older lung cancer patients

Low-risk atrial fibrillation patients fare better without antithrombotic therapy, study finds

URI researchers awarded federal funding to improve environmental, behavioral health

Palliative care consults for advanced cancer patients linked to improvement in multiple quality measures

Scientists discover new cell structure responsible for unexplained rejections after organ transplant

High levels of two biomarkers can predict risk for adverse cardiac events, research suggests

Immune cells could be new target to treat type 2 diabetes, hypertension in overweight people

Moderate exercise may benefit patients with hypertrophic cardiomyopathy

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

Researchers use Syngene’s G:BOX Chemi XRQ image analysis system in cardiac research

Northumbria University uses G:BOX Chemi XX6 multi-application imager in biomedical research

Nocturia is the top cause of sleep disturbance

Study finds reductions in volume of gray matter in the brains of children with obstructive sleep apnea

Mount Sinai researchers review progress made in using ketamine and other therapies to treat depression

Fat cells take over production of uridine from liver during fasting

Why don’t patients always discuss hyperglycemia with their doctor?

The Sohn Conference Foundation funds research to advance understanding of how pediatric cancer metastasizes

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Heart Disease News and Research

Latest Heart Disease News and Research

Innovation in neuroscience drug discovery - eBook eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in